MICHAEL BLANKINSHIP: Open Payments
NPI 1780826867 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$88,448 in 136 payments from 17 companies in 2025. Trend: 2023 $9,218 · 2024 $30,416 · 2025 $88,448
Speaker / faculty: $73,203Consulting: $12,529Food & beverage: $2,101Travel & lodging: $422Education: $194
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 48 | $60,010 |
| Galderma Laboratories, L.P. | 9 | $12,513 |
| PFIZER INC. | 5 | $5,136 |
| Regeneron Healthcare Solutions, Inc. | 3 | $4,049 |
| Eli Lilly and Company | 3 | $3,548 |
| GENZYME CORPORATION | 14 | $2,126 |
| E.R. Squibb & Sons, L.L.C. | 16 | $196 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $191 |
| Janssen Biotech, Inc. | 6 | $181 |
| ABBVIE INC. | 12 | $170 |
Products named: NEMLUVIO, DUPIXENT, EBGLYSS, CIBINQO, OLUMIANT, TREMFYA, TALTZ, Sotyktu.
Industry payments across ND — which companies pay providers there.
